Esophageal Cancer: Tumor-Node-Metastasis Staging
Sonia L Betancourt-Cuellar1, Marcelo F K Benveniste1, Diana P Palacio2
1Thoracic Imaging Department, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1478, Houston, TX 77030-4009, USA.
Radiologic Clinics of North America
|February 8, 2021
Summary
Esophageal cancer staging is crucial for treatment. Clinical staging relies on various imaging techniques to determine the extent of the disease for effective management.
Area of Science:
- Oncology
- Gastroenterology
Background:
- Esophageal cancer is a significant global health concern, ranking sixth in worldwide mortality.
- Histologic subtypes vary globally, with squamous cell carcinoma predominant worldwide and adenocarcinoma common in Western countries.
Purpose of the Study:
- To outline the staging system for esophageal cancer.
- To detail the imaging modalities used for clinical staging.
Main Methods:
- Utilizes the American Joint Committee on Cancer and International Union for Cancer Control TNM staging system.
- Employs complementary imaging modalities for clinical staging.
Main Results:
- Separate classifications exist for clinical, pathologic, and postneoadjuvant pathologic stages.
- Clinical TNM determination integrates data from multiple imaging techniques.
Conclusions:
- Accurate staging of esophageal cancer is essential for guiding treatment strategies.
- A combination of endoscopic and radiologic imaging is vital for comprehensive clinical staging.
